Isoptin SR 240 - effective antihypertensive and antiishemic medication
https://doi.org/10.18705/1607-419X-2006-12-3-232-236
Abstract
The review describes data about high antihypertensive efficacy and safety of isoptin SR in patients with arterial hypertension. The results of numerous comparative studies show advantages of isoptin SR related to its metabolic neutrality, symphatolvtic and nephroprotective effects.
References
1. A.Fleckenstein Verapamil. A Drug on the Threshold of the Next Decade // Wissenschaftenverlag Wellingsbüttel GmbH.-1992,- p.9-18.
2. Messerli F.H. //там же.Ч - p.70-82.
3. Novo S., Alaimo G., Abrignani M.G., Longo B., Muratore G., Strano A. Noninvasive blood pressure monitoring evaluation of verapamil slow-release 240-mg antihypertensive effectiveness. Journal of Cardiovascular Pharmacology 1989; 13 (Suppl. 4): S38-S41.
4. Safar M., Benetos A., Juvin Ph. et al. Multicentre trial of the antihypertensive efficacy and safety of Verapamil SR. Act. med. Int. - l’Hypertension 1990; 2: 3-7.
5. Holzgreve H., Distier, Michaelis J., Philipp Th., Wellek S. Verapamil versus hydrochlordthiazide in the treatment of hvpertension: results of long term double blind comparrative trial. Br. Med. J. 1989; 299: 881-886.
6. Stalmach W.J., Rush D.R., Brücker P.C., Holverson H., Huffmann B.L., Kane W.J., Ryan M.F. Managing hypertension in family practice: a nationwide collaborative study of the use of four antihypertensives in the treatment of inild-to-moderate hypertension. J. Amer. Fam. Pract. 1989; 2:172-190.
7. Libretti A., Catalono M. on behalf of the SLIP study gropup. Lipid profile during antihypertensive treatment - the SLIP study. Drugs 1993; 46 (Suppl. 2): 16-23.
8. Agabiti Rosei E., Dal Plau C., Leonetti G. et al. The verapamil in hypertension and atherosclerosis study (VHAS): results of longterm randomised treatment with either verapamil or chlorthalidone oncarotidintima-mediathickness.J. Hypertens. 1997; 15:1337-1344.
9. Zanchetti A., Magnani B., Dal Plau C. et al. Clinical results of the verapamil in hypertension and atherosclerosis study (VHAS). J. Hypertens. 1998; 16:1667-1676.
10. Bakris G.L., Copley J.B., Vicknair N. et al. Verapamil SR has similar nephroprotective properties to lisinopril and is significantly better in comparison to atenolol. Kidney International, vol.50 (1996),1641-1659.
11. Lefrandt J.D., van Roon A.M., van Gessel et al. Improved Short-Term Blood Pressure Control by treatment with calcium antagonists in perients with mild or moderate hypertension. J Hypertension 1999, 17 (Suppl.3).
12. Gillman M.W. et al. Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J 1993; 125:1148-1154. ОБЗОР
13. Grossman E., Messerli F.H. Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure. AmJ Cardiol 1997; 80:1453-1458.
14. Halperin A.K. A Comparison of the Effects of Nifedipine and Verapamil on Exersice Performane in Patients With Mild to Moderate Hypertension. American Journal of Hypertension. 1993; 6: 1025-1032.
15. Palmer A., Fketocher A., Hamilton G., Muriss S., Bulpitt O. A comparison of verapamil and nifedipine on quality of life. Brit J Clin Pharmacol 1990; 30:365-370.
16. Арабидзе Г.Г., Рогоза A.H., Дмитриев B.B. и соавт. Изоп-тин-ретард 240 мг при лечении мягкой и умеренной артериальной гипертонии. Тер. архив, 1993; 9: 50-52.
17. Арабидзе Г.Г., Дмитриев В.В., Рогоза А.Н. Новый подход к оценке эффективности гипотензивной терапии у больных мягкой и умеренной артериальной гипертонией на примере применения Изоптина-ретарда. Клин, медицина, 1994; 5: 27-30.
18. Глотов М.H., Пшеницин А.И., Мазур H.A., Малов А.Г. Оценка влияния Изоптина-ретарда на центральную гемодинамику и показатели диастолической функции желудочка у больных гипертонической болезнью. Тер. архив. 1993; 9: 29-31.
19. Маколкин В.И., Подзолков В.И. Изоптин. Эволюция взглядов от Флекенштейна до наших дней. Тер. архив 1998; 10:79-81.
20. Подзолков В.И., Корпус Д.Л., Косева К.И., Маколкин В.И. Эффективность Изоптина SR у больных гипертонической болезнью. Клин, фармакология и терапия, 1998; 7(4): 37-38.
21. Кукес В.Г., Красных Л.М., Теплоногова Е.В. Применение Изоптина SR 240 в лечении артериальной гипертонии. Клиническая фармакология и терапия 1998; 8:50-52.
22. Pepine C.J., Handberg E., Cooper-De-Hoff R. et al. A Calcium Antagonist vs Non-Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease. The International Verapamil-Trandolapril Study (INVEST): A Randomized Controlled Trial. JAMA, December 3, 2003-Vol. 290,№ 21:2805-2816.
23. Silber S., Vogler A., Theisen К. Equal anti-ischemic properties of isosorbide dinitrate plus propranolol - a randomised, double-blind and crossover study. Z. Kardiol., Suppl.3 (1986), 100-105.
24. Pallone N.M. Effect of Calcium Antagonists in the Treatment of Silent Ischemic Heart Disease. Curr. Ther. Res., 45 (1989), 339-346.
25. Rehnqvist N., Hjemdahl P., Billing E. et al. Effect of metoprolol vs. verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm. Eur. Heart J. 1996; 17: 76-81.
26. Jesperson C.M., Fischer Hansen J. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II - DAVIT II). Am J Cardiol 1990;66:779-785.
27. Rengo F., Carbon P., Pathor M. et al. A conrolled trial in patients after myocardial infarction: results of the Calcium antagonist Reinfarction Italian Studv. Am. J. Cardiol. 1996; 77: 365-369.
28. Hoberg E., Dietz R., Frees U. et al. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. Br. Heart J. 1994; 71: 254-260.
Review
For citations:
Makolkin V.I. Isoptin SR 240 - effective antihypertensive and antiishemic medication. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2006;12(3):232-236. (In Russ.) https://doi.org/10.18705/1607-419X-2006-12-3-232-236
Views:
1002
Email this article 